EATRIS facilitates academic collaborations with industry. It identifIes scientific & medical expertise and find the capacity to provide access to the latest technologies and core facilities from within our technology platforms.It serves as a single point of contact, provides (legal) support and acts as a negotiator to facilitate project initiation and monitor project execution when needed. Its infrastructure consists of 115+ biomedical research institutes in 14 EU countries.View this resource Bookmark this resource
Through a combination of in-house and external partnerships with a range of regulatory experts and groups, EATRIS can provide regulatory support for most types of product including: Expert opinion, Orphan Drug Designation and Scientific Advice application at the EMA, Pre-clinical and clinical plan development, Informal scientific advice with selected national competent authorities, for highly complex projects,
access to EATRIS Regulatory Database (free of charge) that contains information about the regulatory requirements, guidelines and legislations from 27 EU countries (as well as Norway, Switzerland, Turkey and Israel) regarding drug and medical device development derived from the application of European legislation.
EATRIS supports your investigators in assessing and optimising the translational feasibility and potential of the projects that your are interested in funding. By providing feedback to you and the investigator on issues such as medical need, market and pipeline overview, regulatory pathway, intellectual property and translational tools, you have more confidence in selecting high potential projects, and investigators can optimise their plans according the realities of the development pipeline.View this resource Bookmark this resource